CORRESP Filing
Indaptus Therapeutics, Inc.
Date: Aug. 19, 2025 · CIK: 0001857044 · Accession: 0001641172-25-024756
AI Filing Summary & Sentiment
File numbers found in text: 333-289573
Show Raw Text
CORRESP 1 filename1.htm Indaptus Therapeutics, Inc. 3 Columbus Circle 15th Floor New York, NY 10019 August 19, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: Indaptus Therapeutics, Inc. (CIK 0001857044) Registration Statement No. 333-289573 on Form S-3 (the " Registration Statement ") Ladies and Gentlemen: Indaptus Therapeutics, Inc. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it may become effective on August 20, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at 212-801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration. Very truly yours, INDAPTUS THERAPEUTICS, INC. By: /s/ Nir Sassi Nir Sassi Chief Financial Officer